At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01061 ESSEX BIO-TECH
Market Closed 12-19 16:08:06
3.900
+0.090
+2.36%
High3.910
Low3.800
Vol597.00K
Open3.810
D1 Closing3.810
Amplitude2.89%
Mkt Cap2.21B
Tradable Cap2.21B
Total Shares567.00M
T/O2.30M
T/O Rate0.11%
Tradable Shares567.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Essex Bio-Technology (01061) Announces Monthly Return for November 2025, Reports No Changes in Issued Shares
Essex Bio-Technology Ltd is an investment holding company mainly engaged in the production and sale of biopharmaceuticals for the treatment of body surface trauma and eye injuries. The Company operates its business through three segments. The Surgical segment is engaged in the development, manufacture and sale of Beifuji series products such as Beifuji spray, Beifuji lyophilized powder, Beifuxin gel and others. The Ophthalmology segment is engaged in the development, manufacture and sale of Beifuji series products such as Beifushu eye drops, Beifushu eye gel, Beifushu single-dose eye drops and others. The Provision of Services segment is engaged in the provision of healthtech e-platform related medical services.